maintenance therapy in aml
Published 2 years ago • 346 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
3:47
why maintenance therapy in aml is unnecessary
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
1:57
glasdegib as maintenance therapy in aml and mds
-
5:34
updates on maintenance therapies in aml
-
2:49
maintenance therapy in aml: agents under investigation and future outlooks
-
1:58
maintenance therapy strategies to reduce relapse in aml
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
3:57
the role of post-transplant maintenance therapy in aml
-
2:02
oral azacitidine maintenance in aml with mds-related changes: insights from quazar aml-001
-
8:21
quazar aml-001: a new standard for aml maintenance therapy
-
2:29
flt3 inhibitors as maintenance therapy in aml
-
6:03
quazar aml-001: oral azacitidine as maintenance therapy in aml
-
2:27
low-dose azacitidine and venetoclax as maintenance therapy in patients with aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
2:15
the toxicity of induction therapy in aml
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml